Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 56 non-cytoplasmic 57 78 transmembrane 79 84 cytoplasmic 85 104 transmembrane 105 109 non-cytoplasmic 110 131 transmembrane 132 151 cytoplasmic 152 171 transmembrane 172 203 non-cytoplasmic 204 223 transmembrane 224 258 cytoplasmic 259 278 transmembrane 279 289 non-cytoplasmic 290 309 transmembrane 310 316 cytoplasmic 317 334 transmembrane 335 339 non-cytoplasmic 340 361 transmembrane 362 372 cytoplasmic 373 394 transmembrane 395 400 non-cytoplasmic 401 421 transmembrane 422 441 cytoplasmic
Input: >WP_084933726.1 NCBI__GCF_002095475.1:WP_084933726.1 MQQNIVQQSDGYLNKTPLFQFILLSCLFPLWGCAASLNDILITQFKSVFALSDFASALVQ SAFYGGYFLIAIPASLVIRKATYKLAILMGLVLYIVGCVLFYPASHMATYTMFLAAIFAI AIGLSFLETAANTYSSMIGHRDHATLRLNISQTFYPIGALMGIVLGKYLVFQDGDSLHTQ MAGMNAEQAHAFRLTMLEHTLEPYKYLVMVLVVVMLLFLFTRYPRCKPESSEKSLPSLGE TFRYLAGNRHFKRGIVAQFLYVGMQVAVWSFTIRLALTLGATNERHASNFMIYSFICFFI GKFVANFLMTRFRAEKVLIVYSVLGVITLAWVMFVPNFTAVYAAVFVSVLFGPCWATIYA GTLATVDNKYTEVAGAFIVMSIVGAAFIPAIQGFVSDHLGSMQLAFGVSLLCFAWVGFYF WGELRHKNQAMQAGRLVEDMP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server